Status:
UNKNOWN
A Randomized Controlled Study on the Treatment of Sacral Canal Cysts With Sacral Canal Reinforcement
Lead Sponsor:
Peking University Third Hospital
Collaborating Sponsors:
Beijing Municipal Science & Technology Commission
Conditions:
Tarlov Cysts
Eligibility:
All Genders
18-65 years
Phase:
NA
Brief Summary
The subject will treat 68 patients with symptomatic sacral canal cysts as the research object, and adopt a randomized controlled research method, respectively, using two methods of reinforcement and r...
Detailed Description
In this subject, a cohort observation method was used to observe 52 patients with two types of surgical removal of hematoma in the basal ganglia under the guidance of frontal ultrasound through keyhol...
Eligibility Criteria
Inclusion
- Symptomatic nerve root cysts diagnosed by MRI
- Intact cyst capsule, no defect of sacral canal lamina
- No other diseases of nervous system, pelvic floor and important organs
- Agree inclusion
Exclusion
- a ) Non-radiculent cysts or asymptomatic cysts b) Cysts cause severe bone erosion to lamina resorption c) Combined with other diseases of nervous system, pelvic floor and important organs d) Disagree to join e) Cannot complete follow-up -
Key Trial Info
Start Date :
July 1 2020
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
June 30 2022
Estimated Enrollment :
68 Patients enrolled
Trial Details
Trial ID
NCT04465305
Start Date
July 1 2020
End Date
June 30 2022
Last Update
July 8 2021
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Peking University Third Hospital
Beijing, Haidian, China, 100191